Search results
Results from the WOW.Com Content Network
Resistant hypertension: add spironolactone ACC / AHA 2017 [13] General <130/80 BP > 130/80: Lifestyle changes and monotherapy with thiazide-type diuretic, ACEI/ARB, and/or CCB BP >20/10 above target: Lifestyle changes and two from different classes: thiazide-type diuretic, ACEI/ARB, and/or CCB JNC 8 2013 [1] General age ≥60 General age <60 ...
Guidelines for treating resistant hypertension have been published in the UK [45] and US. [46] It has been proposed that a proportion of resistant hypertension may be the result of chronic high activity of the autonomic nervous system, known as "neurogenic hypertension". [47] Low adherence to treatment is an important cause of resistant ...
Prehypertension is now referred to as "elevated blood pressure" by the American College of Cardiology (ACC) and the American Heart Association (AHA). [2] The ACC/AHA define elevated blood pressure as readings with a systolic pressure from 120 to 129 mm Hg and a diastolic pressure under 80 mm Hg, [3] Readings greater than or equal to 130/80 mm ...
The 15 best subscription gifts of 2024. Show comments. Advertisement. Search Recipes. Berry Gratin. Between the Sheets. S’Mores Cupcakes. S'More Pie. Soft Pretzels. Bing Cherry Breakfast Clafoutis.
The commissioner of the New York Police Department said there are "no specific credible threats" to the New Year's Eve celebration in Times Square.
In addition, hypertension precedes heart failure in 90% of cases, [7] and the majority of heart failure in the elderly may be attributable to hypertension. [17] Hypertensive heart disease was estimated to be responsible for 1.0 million deaths worldwide in 2004 (or approximately 1.7% of all deaths globally), and was ranked 13th in the leading ...
From Boeing's turbulence and a catastrophic hurricane, to Donald Trump's election victory, "Sunday Morning" host Jane Pauley looks back at key events of a year that was monumental.
The American Journal of Hypertension is a monthly peer-reviewed medical journal covering the field of cardiovascular medicine. It is published by Oxford University Press and the editor-in-chief is Ernesto L. Schiffrin (McGill University). According to the Journal Citation Reports, the journal has a 2022 impact factor of 3.2. [1]